Cervical cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of cervical cancer, 2015-2017, UK.

Deaths

Deaths from cervical cancer, 2015-2017, UK.

Survival

Survive cervical cancer for 10 or more years, 2013-2017, England

Preventable cases

Cervical cancer cases are preventable, UK, 2015

  • There are around 3,200 new cervical cancer cases in the UK every year, that's more than 8 every day (2015-2017).
  • In females in the UK, cervical cancer is the 14th most common cancer, with around 3,100 new cases in 2017.
  • Cervical cancer accounts for 2% of all new cancer cases in females in the UK (2017).
  • Cervical cancer accounts for less than 1% of all new cancer cases in females and males combined in the UK (2017).
  • Incidence rates for cervical cancer in the UK are highest in females aged 30 to 34 (2015-2017).
  • Each year around a tenth (9%) of all new cervical cancer cases in the UK are diagnosed in females aged 75 and over (2015-2017).
  • Since the early 1990s, cervical cancer incidence rates have decreased by a quarter (25%) in females in the UK (2015-2017).
  • Over the last decade, cervical cancer incidence rates have remained stable in females in the UK (2015-2017).
  • Around a quarter of cervical cancer cases are diagnosed late in Northern Ireland (2010-2014).
  • Cervical cancer incidence rates are likely to fall in future decades, according to projections accounting for the expected impact of HPV vaccination.
  • Cervical cancer in England is more common in females living in the most deprived areas.
  • Cervical cancer is more common in White females than in Asian females, but similar to Black females, but Asian and Black females are similar to each other.
  • An estimated 34,800 women who had previously been diagnosed with cervical cancer were alive in the UK at the end of 2010.

See more in-depth cervical cancer incidence statistics

  • There are around 27,500 new cervical carcinoma in situ cases in the UK every year, that's 75 every day (2015-2017).
  • In females in the UK, cervical carcinoma in situ accounted for around 25,200 new cancer cases in 2017.
  • Incidence rates for cervical carcinoma in situ in the UK are highest in females aged 25 to 29 (2015-2017).
  • Each year less than 1% (0%) of all new cervical carcinoma in situ cases in the UK are diagnosed in females aged 75 and over (2015-2017).
  • Since the early 1990s, cervical carcinoma in situ incidence rates have increased by more than a tenth (12%) in females in the UK (2015-2017).
  • Over the last decade, cervical carcinoma in situ incidence rates have remained stable in females in the UK (2015-2017).

See more in-depth in situ cervical carcinoma incidence statistics

  • There are around 850 cervical cancer deaths in the UK every year, that's more than 2 every day (2015-2017).
  • In females in the UK, cervical cancer is the 19th most common cause of cancer death, with around 850 deaths in 2017.
  • Cervical cancer accounts for 1% of all cancer deaths in females in the UK (2017).
  • Cervical cancer accounts for less than 1% of all cancer deaths in females and males combined in the UK (2017).
  • Mortality rates for cervical cancer in the UK are highest in females aged 85 to 89 (2015-2017).
  • Since the early 1970s, cervical cancer mortality rates have decreased by three-quarters (75%) in females in the UK.
  • Over the last decade, cervical cancer mortality rates have decreased by around a fifth (21%) in females in the UK.
  • Mortality rates for cervical cancer are projected to fall in future decades.
  • Cervical cancer deaths in England are more common in females living in the most deprived areas.

See more in-depth cervical cancer mortality statistics

  • Around 8 in 10 (81.1%) of women diagnosed with cervical cancer in England survive their disease for one year or more (2013-2017).
  • Around 6 in 10 (61.4%) of women diagnosed with cervical cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that around 1 in 2 (51.2%) of women diagnosed with cervical cancer in England survive their disease for ten years or more (2013-2017).
  • Cervical cancer survival in England is highest for women diagnosed aged under 40 years old (2009-2013).
  • Around 9 in 10 women in England diagnosed with cervical cancer aged 15-39 survive their disease for five years or more, compared with around a quarter of women diagnosed aged 80 and over (2009-2013).
  • Cervical cancer survival is improving and has increased in the last 40 years in the UK.
  • In the 1970s, almost half of women diagnosed with cervical cancer survived their disease beyond ten years, now it's almost two-thirds.
  • When diagnosed at its earliest stage, more than 9 in 10 (96%) people with cervical cancer will survive their disease for one year or more, compared with 1 in 2 (50%) people when the disease is diagnosed at the latest stage.
  • Five-year relative survival for cervical cancer in women is below the European average in England, Wales and Scotland but similar to the European average in Northern Ireland.

See more in-depth cervical cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 142 UK females will be diagnosed with cervical cancer in their lifetime.
  • 99.8% of cervical cancer cases in the UK are preventable.
  • 99.8% of cervical cancer cases in the UK are caused by infections.
  • 21% of cervical cancer cases in the UK are caused by smoking.

See more in-depth cervical cancer risk statistics

  • 'GP referral' is the most common route to diagnosing cervical cancer.
  • 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
  • 53% of patients diagnosed with cervical cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 40% of patients diagnosed with cervical cancer have radiotherapy as part of their primary cancer treatment.
  • 33% of patients diagnosed with cervical cancer have chemotherapy as part of their primary cancer treatment.
  • Around 7 in 10 (70-73%) of women in Great Britain who are eligible for cervical screening are screened with a definitive usable result for their age.
  • Cervical screening coverage in England and Scotland is falling slowly.
  • More than 9 in 10 women in Great Britain who have cervical screening receive a negative (normal) result.
  • Cervical cancer is found in between 1 and 30 per 1,000 women in England with an abnormal screening result.

See more in-depth cervical cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.